INK PharmaSolutions FZCO™ and Katalyze AI Form Strategic Global Partnership

JUMEIRAH, UAE - Sept. 23, 2025 - PRLog -- Dubai (UAE) and Toronto (Canada) – INK PharmaSolutions FZCO™ and Katalyze AI today announced a strategic alliance to expand access to advanced AI-driven solutions for pharmaceutical, biotech, and healthcare organizations across North America, the Middle East, and India.

Under this partnership, INK PharmaSolutions FZCO™, led by Managing Directors Daanyaal Bandukwala and Nicole Serena, will act as Katalyze AI's distributor and strategic partner across:

• Canada
• United States & Mexico
• Middle East (GCC + broader MENA)
• India

Partnership Benefits

This collaboration brings together Katalyze AI's proprietary platforms—Digityze AI for document digitization and the Operational Data Platform (ODP) for real-time analytics—with INK PharmaSolutions' global reach and regional expertise.

The partnership is designed to:

• Expand presence in highly regulated and strategically important life sciences markets.
• Accelerate adoption of AI-driven solutions by leveraging INK PharmaSolutions' trusted industry relationships.
• Strengthen market impact by aligning Katalyze AI's innovation with INK PharmaSolutions' ability to bridge global markets.
• Create shared momentum by combining technological innovation with commercialization expertise.

Quotes

"Our collaboration with Katalyze AI reflects our shared vision to transform life sciences with innovation that is both practical and impactful."

— Daanyaal Bandukwala, Managing Director, INK PharmaSolutions FZCO™

"This partnership is about more than distribution…it's about enabling change. Together, we're creating pathways for organizations to adopt AI confidently and effectively across regions that demand both innovation and regulatory precision."

— Nicole Serena, Managing Director, INK PharmaSolutions FZCO™

"By combining INK PharmaSolutions' global reach and market expertise with our proprietary AI platforms, we are not only accelerating adoption across highly regulated regions, but also helping manufacturers deliver critical therapies to patients faster, with greater consistency and reliability."

— Reza Farahani, CEO, Katalyze AI

About INK PharmaSolutions FZCO™

INK PharmaSolutions FZCO™ is a global partner to the pharmaceutical, biotech, and healthcare industries, driving innovation, advancing success, and delivering solutions that shape the future of global healthcare.

With expertise in consulting, distribution, industry education, and strategic partnerships, INK PharmaSolutions FZCO™ works across North America, Europe, the Middle East and North Africa (MENA), India, and beyond—bridging markets and supporting organizations in navigating complex regulatory and commercial landscapes.

About Katalyze AI

Katalyze AI is an AI company with proprietary models built specifically for pharmaceutical manufacturing. Its GxP-ready platform structures manufacturing data (paper-based records, PDFs, spreadsheets) into compliant, analytics-ready datasets, enabling optimized production, improved yields, and faster decision-making.

The company serves clients across North America, Europe, and Asia, including CDMOs and manufacturers of complex biologics and advanced therapeutics.